Member Info for BlahBlahDoh

Hello. Looking at the prospects for this company, it seems like a good business, with revenue starting to flow and a big backlog of non-Covid work making the future seem bright. Recurring revenue gives long term potential. The recent proposal though, is a massive leap in growth for a small enterprise, making it a big risk/reward bet in the short term. How do current investors feel about the placing at 70p ?

Chairman David Potter is retiring, Gresham House are to review the whole investment strategy.

Despite big gains over the last few years, the trust remains at a discount to Net Asset Value, which restricts growth. The review aims to consider options for overcoming this.

No surprise that Samsung caught stealing again (from Acorn), but astonishing that the jury " determined that the infringement wasn't willful." I suppose that counts as a win for Samsung's lawyers. So presumably they just found the IP by accident, didn't know it belonged to anyone, and didn't bother to check - could happen to anyone ( :

Not as pessimistic as some here - it's a delay of a few months, not a year, unless you think the trial will be delayed until October 2022.

Yea, though Nano's patents now have to walk through the valley of the shadow of death, fear no Samsung.

I agree ceilidhdan, profit for FY2020 seems preposterous since they were so far down at the interim stage. However, I think a £6-7m loss is far too pessimistic. CF did a lot of deals in the second half, and he has guided that some will be "pleasantly suprised" by the FY results, perhaps you'll be one of them! I'd guess a narrowing of losses to £1-2m demonstrating a decisive turnaround, coupled with a forward looking statement describing completely transformed prospects.

Business panning out even better than expected, continuing the momentum from the terrific February trading update. Price has drifted down since then, but all the indications are that this business has gained serious traction and the revenue tap has started flowing strongly.

How terribly British. Nebba surrender

Slightly off-topic, but worth noting that (according to Bloomberg) only 8.2% of Russians have been vaccinated despite their space-race branded jab being officially approved way back in August, with great fanfare and boasting by Poison Czar Putin. Makes Boris look almost competent.

https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/

I think you've put a bit of a negative spin on the Edison comment ddubya, although I agree the stronger possibility of near term dilution probably explains the SP action.

Edison say that the improved position makes it easier to raise funding. The only reason they give for it being likely is the prospect of large scale production at Runcorn happening next year, with associated costs. That should have already been in their "model" (i.e. guess), so they need to give a better reason for suddenly raising this as an issue. Long-termers here know they have been wrong before. They decline to give an estimate of the amount to be raised, but with breakeven estimated at £6m, it seems reasonable to think that the amount of extra working capital needed would be quite a small number, particularly since they already have an unused facility.

Regardless of dilution, the stronger and closer prospect of volume production is undoubtedly good news, as is the slightly improved balance sheet.

Ex-div date is actually 28th May, according to the RNS:

"The interim dividend of 6.05p per share will be paid on 18 June 2021 to shareholders on the register at the close of business on 28 May 2021"

True NMJ. Defensive moves last year were entirely appropriate and highly effective. With margin improvements now likely for the foreseeable future, customers supported and retained, and a massive ongoing buyback fund, Sage are sitting pretty. The acceleration of the transition to recurring revenue is another big positive, and the dividend boost is icing on the cake. Well done management.

In an earlier FT article, Foley seemed to say he wasn't talking to any private equity firms, but didn't oppose a deal if it was in shareholders interests. Maybe the market interprets one door closing (Schroders) as another one opening?

The main attraction for predators is presumably the incongruously low valuation for a FTSE 100 constituent which has proven more solid and reliable than most of it's peers. M&G also seems to pivoting away from old fund management regimes into something new, so there may be some actual business logic to the timing of a reconfiguration via M&A.

M&G can get a lot higher purely on fair value based on fundamentals, imo, and there are major opportunities for growth too, home and abroad. Market shouldn't need takeover rumours to spot the obvious undervaluation here, it's been apparent to the cognoscenti since launch ( :

The Jackson demergeathon has moonwalked into H2.
Pru are chewing our slippers. Bad Pru.

CFO awarded shares worth about £430K - his holding is now bigger than yours

Wouldn't you expect Mintz to be far more persuasive, aggressive and effective than the Kaist lawyers though? They nailed the Markman. Samsung attempts to delay and whittle could also face a publicity backlash like they have never seen before if UK journalists sniff the story. They should really be considering their options, imo, but will probably just stumble on.

Contract RNS is a mild fillip, extending the cash runway a bit more, keeping the engine ticking

One reason ORPH are down is American inflation. It makes no sense whatsoever, but it is what it is. As someone said, fundamentals are bullish, so hang on till the end of the bucking rodeo y'all. Yee Hah!

Pleasing results considering the abrupt Nigerian sim-card registration issue. Good to see mobile money and banking services progressing well with strong demand. Growth aplenty for the foreseeable future here, demonstrated clearly with every set of results to date. SP still not really reflecting that. Final div works out at about 1.89p giving a yearly total of around 3p - not bad for a growth company.

Welcome BBN, thanks for taking the time to share your perspective, very useful contribution to the board.

Apologies for harping on about a subject I am failing to comprehend quite spectacularly, but I've looked at the recent RNSs again and reached a different conclusion. Contrary to my previous posts, the Black Rock CFD position looks like it has not actually changed at all over the two notifications, with the overall effect being, rather, an increase in shareholdings and a small new position in securities lending (which I also don't understand - possibly hedging).

The overall position is up from 6.52 to 6.91 (in terms of percentage of total voting rights), so the simple persons takeaway is a slightly increased exposure for Black Rock.

Wouldn't we expect the PTAB decision to be influenced by this Markman hearing? It seems clear that Samsung misunderstood the patents in a quite dramatic way, their comprehension of them seems to have been utterly misguided and misinformed. They ought to be embarrassed about their profound failure to understand the basics of the process they are using so extensively, and perhaps they need to reconsider the lawyers they are using, who also seem to have got the wrong end of the stick?